Gilead Sciences Contracts & Agreements

Agreement and Plan of Merger, dated February 11, 2024, among CymaBay Therapeutics, Inc., Gilead Sciences, Inc. and Pacific Merger Sub, Inc (Filed With SEC on February 12, 2024)

Gilead Sciences, Inc. Corporate Annual Incentive Plan, amended and restated (Filed With SEC on November 7, 2023)

Underwriting Agreement, dated September 7, 2023, among the Company and Barclays Capital Inc. and Citigroup Global Markets Inc., as representatives of the several underwriters... (Filed With SEC on September 14, 2023)

Ninth Supplemental Indenture, dated as of September 14, 2023, between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National... (Filed With SEC on September 14, 2023)

Form of non-employee director stock option agreement under 2022 Equity Incentive Plan (for grants (Filed With SEC on August 4, 2023)

Form of non-employee director restricted stock unit agreement under 2022 Equity Incentive Plan (for grants (Filed With SEC on August 4, 2023)

GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN (as Amended and Restated January 25, 2023) Termination Date: January 25, 2033 (Filed With SEC on May 5, 2023)

GILEAD SCIENCES, INC. INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN (as Amended and Restated January 25, 2023) Termination Date: January 25, 2033 (Filed With SEC on May 5, 2023)

Form of global employee stock option agreement under 2022 Equity Incentive Plan (4 year vest) (for certain grants commencing in 2023) (Filed With SEC on May 3, 2023)

Form of performance share award agreement - TSR Goals (U.S.) under 2022 Equity Incentive Plan (for grants commencing in 2023) (Filed With SEC on May 3, 2023)

Form of performance share award agreement - Revenue Goals (U.S.) under 2022 Equity Incentive Plan (for grants commencing in 2023) (Filed With SEC on May 3, 2023)

Form of global employee restricted stock unit agreement under 2022 Equity Incentive Plan (4 year vest) (for grants commencing in 2023) (Filed With SEC on May 3, 2023)

Offer Letter between Registrant and Deborah Telman, dated June 2, 2022 (Filed With SEC on May 3, 2023)

Global stock option agreement for Deborah Telman under 2022 Equity Incentive Plan (Filed With SEC on May 3, 2023)

Global restricted stock unit issuance agreement for Deborah Telman under 2022 Equity Incentive Plan (3 year vest) (Filed With SEC on May 3, 2023)

Global restricted stock unit issuance agreement for Deborah Telman under 2022 Equity Incentive Plan (4 year vest) (Filed With SEC on May 3, 2023)

Offer Letter between Registrant and Merdad Parsey, dated September 29, 2019 (Filed With SEC on February 22, 2023)

Form of global employee stock option agreement under 2022 Equity Incentive Plan (4 year vest) (for certain grants commencing in 2022) (Filed With SEC on August 8, 2022)

Form of non-employee director stock option agreement under 2022 Equity Incentive Plan (for grants commencing in 2022) (Filed With SEC on August 8, 2022)

Form of global employee restricted stock unit agreement under 2022 Equity Incentive Plan (4 year vest) (for certain grants commencing in 2022) (Filed With SEC on August 8, 2022)

Form of non-employee director restricted stock unit (Filed With SEC on August 8, 2022)

Gilead Sciences, Inc. 2022 Equity Incentive Plan (Filed With SEC on May 5, 2022)

Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2022) (Filed With SEC on May 4, 2022)

Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2022) (Filed With SEC on May 4, 2022)

Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 202 (Filed With SEC on May 4, 2022)

Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2022) (Filed With SEC on May 4, 2022)

Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2021) (Filed With SEC on May 6, 2021)

Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2021) (Filed With SEC on May 6, 2021)

Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2021) (Filed With SEC on May 6, 2021)

Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2021) (Filed With SEC on May 6, 2021)

Amendment No. 1 to Gilead Sciences, Inc. 2004 Equity Incentive Plan, amended and restated May 10, 2017 (Filed With SEC on February 25, 2021)

Eighth Supplemental Indenture, dated as of September 30, 2020, between the Company and Wells Fargo Bank, National Association, as Trustee (Filed With SEC on September 30, 2020)

Underwriting Agreement, dated September 23, 2020, among the Company and Barclays Capital Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters... (Filed With SEC on September 29, 2020)

Agreement and Plan of Merger, dated September 13, 2020, among Immunomedics, Inc., Gilead Sciences, Inc. and Maui Merger Sub, Inc (Filed With SEC on September 14, 2020)

Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on August 6, 2020)

Form of non-employee director restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on August 6, 2020)

Gilead Sciences, Inc. 2018 Equity Incentive Plan, amended and restated April 7, 2020 (Filed With SEC on August 6, 2020)

Gilead Sciences, Inc. Severance Plan, amended and restated May 5, 2020 (Filed With SEC on August 6, 2020)

Letter Agreement between Registrant and Johanna Mercier, dated May 4, 2020 (Filed With SEC on August 6, 2020)

Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2020) (Filed With SEC on May 6, 2020)

Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on May 6, 2020)

Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on May 6, 2020)

Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (3 year vest) (for grants commencing in 2020) (Filed With SEC on May 6, 2020)

Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2020) (Filed With SEC on May 6, 2020)

Gilead Sciences, Inc. Corporate Annual Incentive Plan, amended and restated January 1, 2020 (Filed With SEC on May 6, 2020)

Gilead Sciences, Inc. Retention Program for Senior Vice Presidents and Executive Vice Presidents (Filed With SEC on May 6, 2020)

Global stock option agreement for Johanna Mercier (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)

Restricted stock unit issuance agreement for Johanna Mercier (for Performance Objectives in 2019-2020) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)

Global restricted stock unit issuance agreement for Johanna Mercier (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)

Offer Letter between Registrant and Merdad Parsey, dated September 29, 2019 (Filed With SEC on May 6, 2020)

Global stock option agreement for Merdad Parsey (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)

Global restricted stock unit issuance agreement for Merdad Parsey (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)

Agreement and Plan of Merger, dated March 1, 2020, among Forty Seven, Inc., Gilead Sciences, Inc. and Toro Merger Sub, Inc (Filed With SEC on March 2, 2020)

Description of Registrant's Securities (Filed With SEC on February 25, 2020)

Offer Letter between Registrant and Laura Hamill, dated August 8, 2018 (Filed With SEC on February 25, 2020)

Severance and General Release Agreement between Registration and Laura Hamill, dated June 6, 2019 (Filed With SEC on February 25, 2020)

Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2019) (Filed With SEC on November 5, 2019)

Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (3 year vest) (for grants commencing in 2019) (Filed With SEC on November 5, 2019)

Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2019) (Filed With SEC on November 5, 2019)

Gilead Sciences, Inc. Severance Plan, amended and restated July 24, 2019 (Filed With SEC on November 5, 2019)

Transition and Severance Agreement dated July 15, 2019 between Registrant and Gregg Alton (Filed With SEC on November 5, 2019)

Transition and Severance Agreement dated July 15, 2019 between Registrant and John McHutchison (Filed With SEC on November 5, 2019)

Letter dated October 11, 2019 between Gilead Sciences, Inc. and Andrew Dickinson (Filed With SEC on October 15, 2019)

Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)

Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)

Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)

Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)

Form of employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)

Form of non-employee director restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)

Gilead Sciences, Inc. 2005 Deferred Compensation Plan, as amended and restated April 19, 2016 (Filed With SEC on August 6, 2019)

Offer Letter dated May 21, 2019 between Registrant and Johanna Mercier (Filed With SEC on August 6, 2019)

Stock option agreement for Daniel ODay under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)

Performance share award agreement for Daniel ODay (for TSR Goals in 2019) under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)

Performance share award agreement for Daniel ODay (for Revenue Goals in 2019) under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)

Form of restricted stock unit issuance agreement for Daniel ODay (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)

Amended and Restated EVG License Agreement between Japan Tobacco Inc., and Registrant, dated November 29, 2018 (Filed With SEC on February 26, 2019)

Master Agreement by and between Registrant, Gilead Sciences K.K. and Japan Tobacco Inc., dated November 29, 2018 (Filed With SEC on February 26, 2019)

Gilead Sciences, Inc. Retention Program for Executive Officers (Filed With SEC on November 6, 2018)

Separation Agreement and Release dated August 6, 2018 between Gilead Sciences, Inc. and John F. Milligan, Ph.D (Filed With SEC on August 7, 2018)

Gilead Sciences, Inc. Corporate Bonus Plan, as amended and restated on January 1, 2019 (Filed With SEC on August 6, 2018)

Seventh Supplemental Indenture, dated as of September 21, 2017, between the Company and Wells Fargo Bank, National Association, as Trustee (Filed With SEC on September 21, 2017)

Underwriting Agreement, dated September 14, 2017, among the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC, as representatives of... (Filed With SEC on September 20, 2017)

AGREEMENT AND PLAN OF MERGER among: KITE PHARMA, INC., a Delaware corporation; GILEAD SCIENCES, INC., a Delaware corporation; and DODGERS MERGER SUB, INC., a Delaware corporation... (Filed With SEC on August 28, 2017)

GILEAD SCIENCES, INC. 2004 EQUITYINCENTIVE PLAN AS AMENDED AND RESTATED May 10, 2017 (Filed With SEC on May 12, 2017)

GILEAD SCIENCES, INC. $500,000,000 1.950% SENIOR NOTES DUE 2022 $750,000,000 2.500% SENIOR NOTES DUE 2023 $1,250,000,000 2.950% SENIOR NOTES DUE 2027 $750,000,000 4.000% SENIOR... (Filed With SEC on September 20, 2016)

SIXTH SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK,NATIONAL ASSOCIATION, AS TRUSTEE Sixth Supplemental Indenture Dated as of September 20, 2016 Supplementing... (Filed With SEC on September 20, 2016)

Exhibit 10.53 (Filed With SEC on August 5, 2016)

GILEAD SCIENCES, INC. CODE SECTION 162(m) BONUS PLAN As Amended and Restated EffectiveMarch 22, 2016 (Filed With SEC on May 17, 2016)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 6, 2016)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on May 6, 2016)

GILEAD SCIENCES, INC. SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION (As Amended and Restated Effective March 8, 2016) TABLE OF CONTENTS (Filed With SEC on March 11, 2016)

Gilead Sciences Corporate Bonus Plan Effective January 1, 2016 (Filed With SEC on February 24, 2016)

GILEAD SCIENCES, INC. $1,000,000,000 1.850% SENIOR NOTES DUE 2018 $2,000,000,000 2.550% SENIOR NOTES DUE 2020 $1,000,000,000 3.250% SENIOR NOTES DUE 2022 $2,750,000,000 3.650%... (Filed With SEC on September 14, 2015)

FIFTH SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK,NATIONAL ASSOCIATION, AS TRUSTEE Fifth Supplemental Indenture Dated as of September 14, 2015 Supplementing... (Filed With SEC on September 14, 2015)

SCHEDULE A SCHEDULED RELEVANT DAYS May 12, 2015 May 14, 2015 May 18, 2015 May 20, 2015 May 22, 2015 May 27, 2015 May 29, 2015 June 2, 2015 June 4, 2015 June 8, 2015 June 10, 2015... (Filed With SEC on August 5, 2015)

JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on August 5, 2015)

THIRD AMENDMENT (REVISED) TO LICENSE AGREEMENT (Filed With SEC on August 5, 2015)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on May 8, 2015)

GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN Adopted November 15, 1991 Amended May 25, 1994 Amended and Restated January 22, 1998 Approved by Stockholders May 27, 1998... (Filed With SEC on May 8, 2015)

GILEAD SCIENCES, INC. INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN Adopted November 3, 2009 Amended and Restated May 8, 2013 Amended and Restated January 22, 2015 Termination Date:... (Filed With SEC on May 8, 2015)

GILEAD SCIENCES, INC. $500,000,000 2.350% SENIOR NOTES DUE 2020 $1,750,000,000 3.500% SENIOR NOTES DUE 2025 $1,750,000,000 4.500% SENIOR NOTES DUE 2045 Underwriting Agreement (Filed With SEC on November 17, 2014)

FOURTH SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK,NATIONAL ASSOCIATION, AS TRUSTEE Fourth Supplemental Indenture Dated as of November 17, 2014 Supplementing... (Filed With SEC on November 17, 2014)

Fifth Amendment to License Agreement (Filed With SEC on November 5, 2014)

GILEAD SCIENCES, INC. STOCK OPTION AGREEMENT (Filed With SEC on August 4, 2014)

GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on August 4, 2014)

THIRD AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on August 4, 2014)

SEVENTH AMENDMENT AGREEMENT (Filed With SEC on May 7, 2014)

GILEAD SCIENCES, INC. $500,000,000 2.050% SENIOR NOTES DUE 2019 $1,750,000,000 3.700% SENIOR NOTES DUE 2024 $1,750,000,000 4.800% SENIOR NOTES DUE 2044 Underwriting Agreement (Filed With SEC on March 7, 2014)

THIRD SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK,NATIONAL ASSOCIATION, AS TRUSTEE Third Supplemental Indenture Dated as of March 7, 2014 Supplementing the... (Filed With SEC on March 7, 2014)

THIRD AMENDMENT (Amendment No. 3) (Filed With SEC on February 25, 2014)

PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS AMENDMENT NO. 1 (Filed With SEC on February 25, 2014)

SEVENTH AMENDMENT AGREEMENT (Filed With SEC on October 31, 2013)

GILEAD SCIENCES, INC. STOCK OPTION AGREEMENT (Filed With SEC on August 1, 2013)

GILEAD SCIENCES, INC. STOCK OPTION AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on August 1, 2013)

GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on August 1, 2013)

GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on August 1, 2013)

GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN Adopted November 15, 1991 Amended May 25, 1994 Amended and Restated January 22, 1998 Approved by Stockholders May 27, 1998... (Filed With SEC on August 1, 2013)

GILEAD SCIENCES, INC. INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN Adopted November 3, 2009 Amended and Restated May 8, 2013 Termination Date: January 22, 2017 (Filed With SEC on August 1, 2013)

GILEAD SCIENCES, INC. 2004 EQUITY INCENTIVE PLAN (1) AS AMENDED AND RESTATED MAY 8, 2013 (Filed With SEC on May 13, 2013)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 8, 2013)

AMENDED AND RESTATED SECOND AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on May 8, 2013)

THIRD AMENDMENT (Amendment No. 3) (Filed With SEC on February 27, 2013)

PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS AMENDMENT NO. 1 (Filed With SEC on February 27, 2013)

PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (Filed With SEC on November 6, 2012)

THIRD AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT (Filed With SEC on September 14, 2012)

GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on August 1, 2012)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 4, 2012)

GILEAD SCIENCES, INC. SEVERANCE PLAN Adopted on March 23, 2004, to be effective January 29, 2003 Amended and Restated on May 9, 2006, to be effective January 1, 2005 Amended and... (Filed With SEC on May 4, 2012)

SECOND AMENDMENT (Amendment No. 2) (Filed With SEC on February 23, 2012)

LICENSE AGREEMENT AMENDMENT NO. 5 (Filed With SEC on February 23, 2012)

SECOND SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, AS TRUSTEE Second Supplemental Indenture Dated as of December 13, 2011... (Filed With SEC on December 13, 2011)

GILEAD SCIENCES, INC. $750,000,000 2.40% SENIOR NOTES DUE 2014 $700,000,000 3.05% SENIOR NOTES DUE 2016 $1,250,000,000 4.40% SENIOR NOTES DUE2021 $1,000,000,000 5.65% SENIOR NOTES... (Filed With SEC on December 8, 2011)

EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among PHARMASSET, INC., GILEAD SCIENCES, INC. and ROYAL MERGER SUB INC. Dated as of November 21, 2011 TABLE OF CONTENTS (Filed With SEC on November 25, 2011)

FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on November 4, 2011)

SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on November 4, 2011)

THIRD AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on November 4, 2011)

FOURTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on November 4, 2011)

SECOND AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 4, 2011)

GILEAD SCIENCES, INC. CODE SECTION 162(m) BONUS PLAN As Amended and Restated Effective January 1, 2011 (Filed With SEC on May 17, 2011)

AGREEMENT AND PLAN OF MERGER BY AND AMONG GILEAD SCIENCES, INC., GILEAD BIOPHARMACEUTICS IRELAND CORPORATION, GILEAD SCIENCES LIMITED, CALISTOGA PHARMACEUTICALS, INC. and... (Filed With SEC on May 9, 2011)

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on May 9, 2011)

GILEAD SCIENCES, INC. STOCK OPTION AGREEMENT (Filed With SEC on May 9, 2011)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 9, 2011)

GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on May 9, 2011)

GILEAD SCIENCES LIMITED PHARMACHEM TECHNOLOGIES (GRAND BAHAMA), LTD. ADDENDUM TO TENOFOVIR DISOPROXIL FUMARATE MANUFACTURING SUPPLY AGREEMENT (Filed With SEC on May 9, 2011)

GILEAD SCIENCES, INC. as Corporation WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of March 30, 2011 SENIOR DEBT SECURITIES CROSS-REFERENCE SHEET (Filed With SEC on April 1, 2011)

FIRST SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, AS TRUSTEE First Supplemental Indenture Dated as of March 30, 2011 Supplementing the... (Filed With SEC on April 1, 2011)

GILEAD SCIENCES, INC. 4.50% SENIOR NOTES DUE 2021 ($1,000,000,000 Aggregate Principal Amount) Underwriting Agreement (Filed With SEC on March 28, 2011)

AGREEMENT AND PLAN OF MERGER dated as of December 19, 2010 by and among GILEAD SCIENCES, INC., ARROYO MERGER SUB, INC., ARRESTO BIOSCIENCES, INC. and HEALTHCARE VENTURES VIII,... (Filed With SEC on February 28, 2011)

AMENDMENT NO. 1 TO AMENDED AND RESTATED CREDIT AGREEMENT AND LIMITEDCONSENT AND WAIVER (Filed With SEC on February 28, 2011)

AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on February 28, 2011)

GILEAD SCIENCES LIMITED.-AMPAC FINE CHEMICALS LLC TENOFOVIR DISOPROXILFUMARATE MANUFACTURING SUPPLY AGREEMENT (Filed With SEC on February 28, 2011)

JPMorgan ChaseBank, National Association Organised under the laws of the United States as a National Banking Association Main Office 1111 Polaris Parkway, Columbus, Ohio 43271... (Filed With SEC on November 8, 2010)

AGREEMENT AND PLAN OF MERGER dated as of June 23, 2010 By and Among GILEAD SCIENCES, INC., COUGAR MERGER SUB, INC., CGI PHARMACEUTICALS, INC. and SH REP,LLC, AS REPRESENTATIVE... (Filed With SEC on August 9, 2010)

EMTRICITABINE MANUFACTURING SUPPLY AGREEMENT AMENDMENT NO. 1 (Filed With SEC on August 9, 2010)

JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association Main Office 1111 Polaris Parkway, Columbus, Ohio 43271... (Filed With SEC on August 9, 2010)

GILEAD SCIENCES, INC. 1.00% CONVERTIBLE SENIOR NOTES DUE 2014 INDENTURE DATED AS OF JULY 30, 2010 WELLS FARGO BANK, NATIONAL ASSOCIATION, TRUSTEE TABLE OF CONTENTS (Filed With SEC on August 2, 2010)

GILEAD SCIENCES, INC. 1.625% CONVERTIBLE SENIOR NOTES DUE 2016 INDENTURE DATED AS OF JULY 30, 2010 WELLS FARGO BANK, NATIONAL ASSOCIATION, TRUSTEE TABLE OF CONTENTS (Filed With SEC on August 2, 2010)

GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on May 10, 2010)

GILEAD SCIENCES, INC. STOCK OPTION AGREEMENT (Filed With SEC on March 1, 2010)

GILEADSCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on March 1, 2010)

GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN Adopted November 15, 1991 Amended May 25, 1994 Amended and Restated January 22, 1998 Approved by Stockholders May 27, 1998... (Filed With SEC on March 1, 2010)

GILEAD SCIENCES, INC. (Filed With SEC on March 1, 2010)

GILEAD SCIENCES, INC. STOCK OPTION AGREEMENT (Filed With SEC on August 5, 2009)

GILEAD SCIENCES, INC. (Filed With SEC on August 5, 2009)

GILEAD SCIENCES, INC. 2004 EQUITY INCENTIVE PLAN (Filed With SEC on August 5, 2009)

GILEAD SCIENCES, INC. (Filed With SEC on August 5, 2009)

GILEAD SCIENCES, INC. 2004 EQUITY INCENTIVEPLAN (1) AS AMENDED AND RESTATEDMAY 6, 2009 (Filed With SEC on May 11, 2009)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 18, 2009)

STOCKHOLDER AGREEMENT (Filed With SEC on March 18, 2009)

GILEAD SCIENCES, INC. 2005 DEFERRED COMPENSATION PLAN (Filed With SEC on February 27, 2009)

GILEAD SCIENCES, INC. SEVERANCE PLAN Adopted on March 23, 2004, to be effective January 29, 2003 Amended and Restated on May 9, 2006, to be effective January 1, 2005 Amended and... (Filed With SEC on February 27, 2009)

ADDENDUM TO TENOFOVIR DISOPROXIL FUMARATE MANUFACTURING SUPPLY AGREEMENT (Filed With SEC on February 27, 2009)

PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (Filed With SEC on February 27, 2009)

To: Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404From: Citibank, N.A.Re: Collared Accelerated Stock BuybackRef. No: As provided in the Supplemental... (Filed With SEC on October 21, 2008)

GILEAD SCIENCES, INC. 2004 EQUITYINCENTIVE PLAN(1) (Filed With SEC on August 11, 2008)

GILEAD SCIENCES, INC. SEVERANCE PLAN Adopted on March 23, 2004, to be effective January 29, 2003 Amended and Restated on May 9, 2006, to be effective January 1, 2005 Amended and... (Filed With SEC on August 11, 2008)

GILEAD SCIENCES, INC. 2004 EQUITYINCENTIVE PLAN(1) (Filed With SEC on May 9, 2008)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 2, 2008)

GOLDMAN, SACHS & CO. | 85 BROAD STREET | NEW YORK, NEW YORK 10004 |TEL: 212 ###-###-#### (Filed With SEC on May 2, 2008)

GILEAD SCIENCES LIMITED.-AMPAC FINE CHEMICALS LLC TENOFOVIR DISOPROXIL FUMARATE MANUFACTURINGSUPPLY AGREEMENT (Filed With SEC on May 2, 2008)

GILEAD SCIENCES, INC. 2004 EQUITYINCENTIVE PLAN1 AS AMENDED ANDRESTATED OCTOBER 22, 2007 (Filed With SEC on February 27, 2008)

GILEAD SCIENCES, INC. 2005 DEFERRED COMPENSATION PLAN (Filed With SEC on February 27, 2008)

GILEAD SCIENCES, INC. SEVERANCE PLAN Adopted on March 23, 2004, to be effective January 29, 2003 Amended and Restated on May 9, 2006, to be effective January 1, 2005 Amended and... (Filed With SEC on February 27, 2008)

COMMERCIALIZATION AGREEMENT BETWEEN GILEAD SCIENCES LIMITED (Filed With SEC on February 27, 2008)

GILEAD SCIENCES, INC. STOCK OPTION AGREEMENT (Filed With SEC on February 27, 2008)

GILEAD SCIENCES, INC. (Filed With SEC on February 27, 2008)

GILEAD SCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on December 19, 2007)

AMENDED AND RESTATED (Filed With SEC on December 19, 2007)

PARENT GUARANTY AGREEMENT (Filed With SEC on December 19, 2007)

GILEAD SCIENCES, INC. SEVERANCE PLAN (As Amended and Restated Effective May 8, 2007) Adopted onMarch 23, 2004, to be effective January 29, 2003 Amended and Restated on May 9,... (Filed With SEC on August 9, 2007)

GILEAD SCIENCES LIMITED PHARMACHEM TECHNOLOGIES (GRAND BAHAMA), LTD. (Filed With SEC on August 7, 2007)

GILEAD SCIENCES, INC. 2004 EQUITYINCENTIVE PLAN1 (Filed With SEC on May 11, 2007)

GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 11, 2007)

GILEAD SCIENCES, INC. EMPLOYEECONFIDENTIAL INFORMATION AND INVENTIONS AGREEMENT (Filed With SEC on February 27, 2007)

PERFORMANCE SHARE AWARD AGREEMENT Performance Share Award #<<Performance Shares>>«NUM» (Filed With SEC on February 27, 2007)

AMENDED AND RESTATED (Filed With SEC on November 6, 2006)

SIXTH AMENDMENT AGREEMENT (Filed With SEC on November 6, 2006)

RESTRICTED STOCK AWARD AGREEMENT Restricted Stock Award #<<RestrictedShares>>«NUM» (Filed With SEC on November 6, 2006)

DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on November 6, 2006)

AGREEMENT AND PLAN OF MERGER BY AND AMONG (Filed With SEC on November 6, 2006)

AGREEMENT AND PLAN OF MERGER BY AND AMONG GILEAD SCIENCES, INC., (Filed With SEC on October 5, 2006)

among (Filed With SEC on August 4, 2006)

EMTRICITABINE MANUFACTURING SUPPLY AGREEMENT (Filed With SEC on August 4, 2006)

GILEAD SCIENCES, INC. 2005 DEFERRED COMPENSATION PLAN TABLE OF CONTENTS (Filed With SEC on May 11, 2006)

GILEAD SCIENCES, INC. SEVERANCE PLAN (As Amended and Restated Effective January 1, 2005) Adopted onMarch 23, 2004, to be effective January 29, 2003 Amended and Restated on May 9,... (Filed With SEC on May 11, 2006)

GILEAD SCIENCES, INC. 2004 EQUITY INCENTIVE PLAN1 (Filed With SEC on May 11, 2006)

CERTIFICATE OF AMENDMENT TO THE RESTATED (Filed With SEC on May 11, 2006)

CERTIFICATE OF AMENDMENT TO CERTIFICATE OF DESIGNATION (Filed With SEC on May 11, 2006)

AMENDED AND RESTATED (Filed With SEC on May 3, 2006)

GILEAD SCIENCES, INC. 0.50% Convertible Senior Notes due 2011 (Filed With SEC on April 25, 2006)

GILEAD SCIENCES, INC. 0.625% Convertible Senior Notes due 2013 (Filed With SEC on April 25, 2006)

REGISTRATION RIGHTS AGREEMENT DATED AS OF APRIL 25, 2006, BY AND AMONG (Filed With SEC on April 25, 2006)

GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 3, 2006)

TollManufacturing Agreement by and among Gilead Sciences Limited Unit 13, Stillorgan Industrial Park Blackrock, Co. Dublin, Ireland Gilead Sciences, Inc. (Filed With SEC on March 3, 2006)

Shares (Filed With SEC on February 22, 2006)

GILEAD SCIENCES, INC. NONSTATUTORY STOCK OPTION (Filed With SEC on February 22, 2006)

Gilead Sciences CorporateBonus Plan US Employees Effective January 1, 2006 (Filed With SEC on February 22, 2006)

GILEAD SCIENCES, INC. (Filed With SEC on February 22, 2006)

TERM LOAN AGREEMENT (Filed With SEC on December 27, 2005)

PARENT GUARANTY AGREEMENT (Filed With SEC on December 27, 2005)

SUBSIDIARY GUARANTY AGREEMENT (Filed With SEC on December 27, 2005)

CREDIT AGREEMENT (Filed With SEC on December 27, 2005)

SUBSIDIARY GUARANTY AGREEMENT (Filed With SEC on December 27, 2005)

GILEAD WORLD MARKETS, LTD.-PHARMACHEM TECHNOLOGIES (GRAND BAHAMA), LTD. TENOFOVIR DISOPROXIL FUMARATE MANUFACTURING SUPPLY AGREEMENT (Filed With SEC on November 4, 2005)

ROYALTY SALE AGREEMENT (Filed With SEC on November 4, 2005)

LICENSE AGREEMENT (Filed With SEC on May 6, 2005)

GILEADSCIENCES, INC. 2004EQUITY INCENTIVE PLAN ASAMENDED JULY 29, 2004 (Filed With SEC on August 6, 2004)

Mark L. Perry SeniorBusiness Advisor PrincipalActivities (Filed With SEC on May 5, 2004)

MASTER CLINICAL AND COMMERCIAL SUPPLY AGREEMENT AMONG GILEAD WORLD MARKETS, LIMITED AND GILEAD SCIENCES, INC. AND PATHEON INC. JANUARY 1, 2003 MASTER CLINICAL AND COMMERCIAL... (Filed With SEC on March 11, 2004)

Toll Manufacturing Agreement by and among Gilead WorldMarkets, Ltd QueensgateHouse South ChurchStreet PO Box 1234 GT Grand Cayman Cayman Islands GileadSciences, Inc. 333... (Filed With SEC on March 11, 2004)

LICENSINGAGREEMENT (Filed With SEC on March 11, 2004)

AMENDMENT NO. 1 TO LICENSING AGREEMENT (Filed With SEC on March 11, 2004)

AMENDMENT NO. 2 TO LICENSING AGREEMENT (Filed With SEC on March 11, 2004)

AMENDMENTNO. 3 TO LICENSING AGREEMENT (Filed With SEC on March 11, 2004)

GlaxoSmithKline Letterhead (Filed With SEC on March 11, 2004)

LEASEAGREEMENT (Filed With SEC on August 14, 2003)

GILEAD SCIENCES, INC. SEVERANCE PLAN (as adopted effective January 29, 2003) TABLE OF CONTENTS (Filed With SEC on May 15, 2003)

THIRD AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on May 15, 2003)

GILEADSCIENCES, INC. ISSUER TO J.P.MORGAN TRUST COMPANY, NATIONAL ASSOCIATION TRUSTEE INDENTURE Datedas of December 18, 2002 2.00%CONVERTIBLE SENIOR NOTES DUE DECEMBER 15, 2007... (Filed With SEC on March 14, 2003)

Gilead Sciences, Inc. 2.00% Convertible Senior Notes due December 15, 2007 Registration Rights Agreement (Filed With SEC on March 14, 2003)

GILEADWORLD MARKETS, LTD. and PPG TENOFOVIR DF MANUFACTURING SUPPLY AGREEMENT (Filed With SEC on March 14, 2003)

EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2002)

Category

Industry

Companies

Contracts

Gilead Sciences Contracts & Agreements